Buğra Sağlam

5PUBLICATIONS
17CO-AUTHORS
Haematological tumoursPredictive and prognostic markersOphthalmology and optometry not elsewhere classifiedMedical infection agents (incl. prions)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 14, 2021
The outcome of COVID-19 in patients with hematological malignancy.

Pınar Tığlıoğlu, Murat Albayrak, Mesut Tığlıoğlu

|Nov 15, 2021
Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.

Fatma Yılmaz, Murat Albayrak, Pınar Tığlıoğlu

|Aug 23, 2021
Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect.

Mesut Tığlıoğlu, Pınar Tığlıoğlu, Abdulkerim Yıldız

Pageof 1